Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease colorectal cancer
Phenotype C0494165|liver metastases
Sentences 110
PubMedID- 22962603 Firstly, we validated the suppression of mir-214 in human hcc by real-time quantitative rt-pcr (qrt-pcr) in 20 paired tumor and non-tumor liver tissues of hcc patients and 10 histologically normal liver tissues from colorectal cancer patients with liver metastases.
PubMedID- 22206922 Background: intensive medical treatment increases resection rate of liver metastases in patients with metastatic colorectal cancer (mcrc).
PubMedID- 20649733 Objective: to evaluate the effect of prophylactic regional liver chemotherapy during the perioperative period on improving survival and preventing liver metastases in patients with colorectal cancer (crc).
PubMedID- 22850548 Methods: fifty colorectal cancer patients with liver metastases received neoadjuvant chemotherapy +/- bevacizumab supplementation.
PubMedID- 24699568 The formation of liver metastases in colorectal cancer patients is the primary cause of patient death.
PubMedID- 22242554 Traditionally, resection of the primary tumor has been advocated in order to prevent complications of the primary tumor colorectal cancer in patients with synchronous liver metastases.
PubMedID- 22209659 Incidence of synchronous liver metastases in patients with colorectal cancer in relationship to clinico-pathologic characteristics.
PubMedID- 20110289 Patients and methods: colorectal cancer patients with isolated liver metastases, who underwent ihp, were included in this study.
PubMedID- 22560316 Study design: we conducted a retrospective cohort study of consecutive colorectal cancer patients with resectable synchronous liver metastases treated between 1993 and 2010, constructing a decision tree comparing simultaneous and staged resections.
PubMedID- 26222850 Secondly, previous studies on colorectal cancer with liver metastases indicated that patients with extra hepatic metastases had poor survival,16,17 and some patients with extra hepatic metastases were included in the current study.
PubMedID- 20977728 Conclusions: although limited by small case number, this study demonstrated a possible role of whole-liver rt in improving hepatic dysfunction and delaying mortality from hepatic failure for end-stage colorectal cancer patients with massive liver metastases.
PubMedID- 26566221 Early assessment of colorectal cancer patients with liver metastases treated with antiangiogenic drugs: the role of intravoxel incoherent motion in diffusion-weighted imaging.
PubMedID- 24659854 Many surgeons support a simultaneous approach as a safe treatment to liver metastases due to colorectal cancer [62–64].
PubMedID- 22409860 One hundred twenty colorectal cancer patients with liver metastases (100 with synchronous metastases, 20 with metachronous) were evaluated.
PubMedID- 21938482 Previous studies have suggested that plasma endostatin levels are elevated in colorectal cancer patients with liver metastases [20].
PubMedID- 21780098 We conducted a phase ii trial to confirm the pharmacokinetic parameters from 3-tesla dynamic contrast-enhanced magnetic resonance imaging (dce-mri) as surrogate biomarkers of bv + folfiri regimen efficacy in colorectal cancer with liver metastases.
PubMedID- 20617435 In a study in colorectal cancer patients with liver metastases, the liver metastases in 9 of 12 patients were visualized with 111in-bevacizumab (fig.
PubMedID- 24358218 liver metastases of human colorectal cancer cells were generated by intrasplenic (isp) injections of 1×105 t-hct 116 cells and 1×106 hct 116 cells into brg nude mice (n = 3 and 3, respectively), followed by splenectomy under isoflurane anesthesia [4].
PubMedID- 23876227 An elevated nlr in colorectal cancer patients with liver metastases receiving only neoadjuvant chemotherapy before surgical resection of liver metastases predicted worse rate of survival [11].
PubMedID- 22993665 Fifteen percent to twenty-five percent of patients affected by colorectal cancer presents with liver metastases at diagnosis.
PubMedID- 20821329 This work investigated 5fu pharmacokinetics in liver metastases of colorectal cancer.
PubMedID- 25061576 Prognostic and predictive value of liver volume in colorectal cancer patients with unresectable liver metastases.
PubMedID- 23497123 We compared three groups, composed of 17 colorectal cancer patients with liver metastases who had undergone at least segmental anatomical hepatic resection (8 patients with and 9 patients without preoperative chemotherapy) and 15 patients in a living liver donor transplantation group in our department since january 2008. the preoperative chemotherapy regimen was oxaliplatin-based in six subjects, irinotecan-based in one subject, and oxaliplatin- and irinotecan-based in one subject.
PubMedID- 25692420 High expression of darpp-32 in colorectal cancer is associated with liver metastases and predicts survival for dukes a and b patients: results of a pilot study.
PubMedID- 24267032 Nine male patients with liver metastases of colorectal cancer were included retrospectively (age, 48 to 76 years (mean 62.8); weight, 73 to 100 kg (mean 85.5)).
PubMedID- 21084828 Most colorectal cancer patients with liver metastases are not resectable upon initial diagnosis.
PubMedID- 25081377 Cryoablation plus chemotherapy in colorectal cancer patients with liver metastases.
PubMedID- 19508508 Aim: to determine the factors affecting the survival in colorectal cancer patients with synchronous liver metastases.
PubMedID- 23035809 Background: liver resection provides one of the best oncological outcomes for liver metastases in patients with colorectal cancer.
PubMedID- 25058762 Simultaneous laparoscopic colectomy and hepatectomy for primary colorectal cancer with synchronous liver metastases appears feasible with low morbidity and favorable outcomes.
PubMedID- 23302476 Objectives: to analyze the survival outcomes of the surgery for colorectal cancer with liver metastases (crclm), and study the mode of multi-disciplinary team (mdt) for crclm.
PubMedID- 22216763 Background: selective internal radiation therapy (sirt) is a new and effective locoregional anticancer therapy for colorectal cancer patients with liver metastases.
PubMedID- 21126340 Specific genomic aberrations in primary colorectal cancer are associated with liver metastases.
PubMedID- 25089107 Methods: colorectal cancer patients with liver metastases resected at the ottawa hospital between january 1, 2003, and december 31, 2009, were identified, and their clinical records were retrospectively reviewed.
PubMedID- 24203162 Interestingly, the expression of both pparβ/δ and cox-2 in tissues of colorectal cancer patients leads to liver metastases, a condition associated with poor prognosis (yoshinaga et al, 2011).
PubMedID- 22934251 To address this question, sequential lung or sequential liver metastases of colorectal cancer patients were analyzed using whole slide image quantification after immunohistochemical staining against cd3, cd8, foxp3, cd68 and granzyme b. the clinical data and interventions were associated with each individual patient and the metastatic lesions.
PubMedID- 24606532 Pure laparoscopic right-sided hepatectomy in the semi-prone position for synchronous colorectal cancer with liver metastases.
PubMedID- 25622583 Objective: to explore the feasibility and safety of laparoscopic radical coloproctectomy and hepatectomy for resectalble colorectal cancer with liver metastases (crclm), and evaluate the survival outcomes of short-middle term for these patients.
PubMedID- 23047645 Hmgb1 is a valuable serum biomarker for early estimation of therapy response and prognosis in colorectal cancer patients with liver metastases undergoing re therapy.
PubMedID- 23700570 The response rate was approximately 20%, and it was difficult to expect long-term survival for most unresectable colorectal cancer patients with liver metastases [31].
PubMedID- 25297902 Is liver transplantation an option in colorectal cancer patients with nonresectable liver metastases and progression on all lines of standard chemotherapy.
PubMedID- 22537902 colorectal cancer with synchronous liver metastases: does global management at the same centre improve results.
PubMedID- 23022595 Two studies found that for liver metastases of colorectal cancer, non-responding lesions had significantly lower pre-treatment mean adcs than responding lesions[36,37], but this was not confirmed in a third study[38].
PubMedID- 24106681 Prospective multicenter phase ii clinical trial of folfiri chemotherapy as a neoadjuvant treatment for colorectal cancer with multiple liver metastases.
PubMedID- 22811880 The management of colorectal cancer patients with liver metastases is a common clinical problem.
PubMedID- 24081807 Cause of death from liver metastases in colorectal cancer.
PubMedID- 23815814 In colorectal cancer with early liver metastases, co-expression of cd133 and cd44 is significantly higher when compared to those without early liver metastases [48].
PubMedID- 23497553 The investigated patient group included nine male subjects with liver metastases of colorectal cancer (mean age 62.8 years, range 48 to 76).
PubMedID- 24394015 As the present case is considered rare, we herein review our previous report on a case of early colorectal cancer with synchronous multiple liver metastases.
PubMedID- 23268036 [a long-term survivor of colorectal cancer associated with multiple liver metastases and peritoneal carcinomatosis treated through a multidisciplinary approach].

Page: 1 2 3